Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 1,900 | 5,700 | 0 | 0 | 0 |
| Cost of Goods | 100 | 100 | N/A | N/A | N/A |
| Gross Profit | 1,800 | 5,600 | N/A | N/A | N/A |
| Operating Expenses | 6,353 | 7,945 | 6,059 | 4,492 | 4,267 |
| Operating Income | -4,453 | -2,245 | -4,159 | -4,492 | -4,267 |
| Other Income | -160 | -158 | 426 | 19 | -158 |
| Pre-tax Income | -4,613 | -2,403 | -3,733 | -4,473 | -4,425 |
| Net Income Continuous | -4,613 | -2,403 | -3,716 | -4,473 | -4,425 |
| Net Income | $-4,613 | $-2,403 | $-3,716 | $-4,473 | $-4,425 |
| EPS Basic Total Ops | -0.30 | -0.16 | -0.26 | -0.53 | -0.66 |
| EPS Basic Continuous Ops | -0.30 | -0.16 | -0.26 | -0.53 | -0.66 |
| EPS Diluted Total Ops | -0.30 | -0.16 | -0.26 | -0.53 | -0.66 |
| EPS Diluted Continuous Ops | -0.30 | -0.16 | -0.26 | -0.53 | -0.66 |
| EBITDA(a) | $-4,453 | $-2,245 | $-6,059 | $-4,492 | $-4,267 |